ICD-10-CM Billable Code

D57.813

Other sickle-cell disorders with cerebral vascular involvement

Clinical Classification Guidelines

Code Also

  • , if applicable: cerebral infarction (I63.-)

Medical Intelligence & Overview

Sickle-cell disorders are a group of inherited blood conditions characterized by abnormal hemoglobin within red blood cells. When these disorders involve cerebral vessels, they can impact brain function and increase the risk of neurological complications. The ICD-10 code D57.813 specifically refers to other sickle-cell disorders that have affected the cerebral vascular system. Recognizing the features of these conditions is essential for understanding their potential health impacts and management strategies.

Causes & Symptoms

Clinical Causes: Inherited genetic mutations affecting hemoglobin production, particularly the sickle cell gene Mutations leading to abnormal hemoglobin S that causes red blood cells to assume a sickled shape A family history of sickle-cell disorders or trait Environmental factors that exacerbate the condition, such as dehydration or extreme physical stress

Key Symptoms: Frequent headaches or migraines Transient neurological episodes, such as weakness or numbness in limbs Recurrent strokes or mini-strokes (transient ischemic attacks) Problems with concentration or memory Seizures in severe cases Focal neurological deficits depending on areas affected

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive medical history, physical examination, and specialized tests, including:

Treatment Protocols: Management aims to prevent complications and alleviate symptoms. Recommended approaches may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D57.813 a billable ICD-10 code?
Yes, D57.813 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D57.813?
Clinical documentation must specify the nature of Other sickle-cell disorders with cerebral vascular involvement and any associated comorbidities for accurate reporting.

Cite this Clinical Reference